SCHEMBL3012744

SCHEMBL3012744

CC(C)(C)OC(=O)C[C@@H](CC1CCC2(CC1)CC2)C(=O)N1C(=O)OCC1Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.37
PLA2G10 O15496 1/20 0.36
PLA2G5 P39877 1/20 0.36
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
KLK7 P49862 4/20 0.34
KLK5 Q9Y337 3/20 0.34
USP2 O75604 1/20 0.33
FAAH O00519 1/20 0.33
IL6ST P40189 1/20 0.33
LTB4R Q15722 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
USP19 O94966 1/20 0.32
IDH1 O75874 1/20 0.32
NAAA Q02083 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PDF Q9HBH1 1/20 0.31
KMT2A Q03164 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3021447 1.00 PPARA (0.37) PPARAPLA2G10PLA2G5CSNK2BCSNK2A1
SCHEMBL3021441 1.00 PPARA (0.37) PPARAPLA2G10PLA2G5CSNK2BCSNK2A1
SCHEMBL13904727 0.93 PPARA (0.40) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL3006140 0.91 PPARA (0.39) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL3006139 0.91 PPARA (0.39) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL16498239 0.91 PPARA (0.39) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL28948933 0.91 PPARA (0.39) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL28948936 0.91 PPARA (0.39) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL28948939 0.91 PPARA (0.39) PPARAPLA2G10PLA2G5KLK7KLK5
SCHEMBL3020667 0.88 PPARA (0.39) PPARACSNK2BCSNK2A1FAAHIL6ST

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100204200-A1 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204200-A1 INHIBITORS OF CATHEPSIN S CTSS, CTSE, CTSV PPARA 2508/4885PLA2G10 956/4885PLA2G5 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.